The pets industry, encompassing various businesses related to the healthcare and daily needs of our furry friends, has recently been a hot topic among investors.

Discover how our AI predicts a 4% decline for Walgreens Boots Alliance (WBA) within the next month, with a 72% chance of a continued downtrend. Learn about the factors influencing this prediction and the broader trends in the Drugstore Chains Industry.

Discover the bearish signals surrounding Walgreens Boots Alliance (WBA) as it enters a projected downtrend continuation. A.I.dvisor's analysis points to a potential decline in WBA's price within the upcoming month. Join us as we explore the factors contributing to this forecast and examine historical data, indicating a high likelihood of a continued downtrend for WBA.

Walgreens Boots Alliance reported a decrease in earnings per share to 33 cents in the fiscal third quarter, compared with $1.38 in the year-ago quarter. Adjusted earnings per share came in at 96 cents, surpassing analysts’ expectations of 92 cents per share. The pharmacy retail company’s sales from continuing operations decreased -4.2 percent from the year-ago quarter to $32.6 billion. The...

On Tuesday, Walgreens Boots Alliance Inc. announced that it will offer same-day delivery service through Uber Eats. The delivery service will be available across 7,800 stores in the U.S.. It can soon be accessed in Puerto Rico. Customers will be allowed to place their orders via the Uber Eats app. “Walgreens provides our customers with seamless health and well-being experiences, and offering...

 

The pharmacy retail company’s adjusted earnings for the quarter came in at 40 cents a share, compared to 2 cents expected by analysts.

Revenue rose +12% year-over-year to $6.12 billion, also topping analysts’ forecast of $5.84 billion.

For its fiscal 2021, Rite Aid hiked its  revenue guidance to between $23.9 billion and $24.2 billion (from its prior projection of $23.5 billion and $24 billion).It expects same- store sales growth to range between 3.5% and 4.5%, (from its prior guidance of between 3% and 4%. ).

"We are pleased with our third-quarter performance as we continue to grow our business and achieve major physical and digital milestones through our RxEvolution strategy," said Rite Aid CEO Heyward Donigan. Donigan also mentioned the launch of the company’s new brand and logo, and said that the company has made “substantial progress” in evolving its merchandise mix to support whole health.

The odds of a continued downward trend are 50%. Following a 3-day decline, the stock is projected to fall further.The odds of a continued upward trend are 50%. The Aroon Indicator entered an Uptrend today.

Pharmacy store chain Walgreens Boots Alliance Inc.  announced that Stefano Pessina will step down from his role as CEO after five years at the company.He will become executive chairman instead. “I want to thank our team members around the world for their extensive achievements in the last five years, as we have fulfilled our purpose to help people lead healthier and happier lives,” said Pessina.

Walgreens Boots Alliance Inc. reported third quarter earnings that missed analysts' expectations.  The retail/wholesale pharmacy company’s adjusted earnings for the three months ending in May came in at 83 cents per share, falling short of the Street consensus estimate of $1.18 per share.In 21 of 29 cases where WBA's RSI Indicator exited the overbought zone, the price fell further within the following month.

Walgreens Boots Alliance’s fiscal third-quarter earnings surpassed analysts’ estimates, as the pharmacy retail giant bounced back with strong prescription drug sales. Walgreens reported adjusted earnings of $1.47 a share for the quarter ended May 31, compared to analysts’ expectations of $1.43. Revenue of $34.59 billion also came in higher than analysts’ estimates of $34.46 billion.Three analysts polled by Refinitiv had expected a 2.9% rise in same-store sales. CEO Stefano Pessina emphasized that after a challenging second quarter, Walgreen has been able to improve its performance in the third quarter and has progressed in line with the goals set.    

The second-largest pharmacy store chain of U.S., Walgreens will sell CBD or cannabis-based products like creams, patches, and sprays in over its 1,500 stores in select states of U.S. like Oregon, Colorado, New Mexico, Kentucky, Tennessee, Vermont, South Carolina, Illinois and Indiana.The products so far will be limited to health and wellbeing services. Walgreens’s venture into CBD products is not unprecedented as rivals like CVS had already introduced CBD-containing topicals, including creams and salves, to stores in eight U.S. states earlier in March. Walgreens now joins retailers who are carefully evaluating the market for cannabis-based products. According to the company, the market is fairly nascent with much to test and explore.

Rite Aid said on Tuesday its chief executive officer would exit as part of a revamp of its leadership, and that it would slash about 400 corporate positions. Read More...

When Walgreens announced its merger with Boots six years ago, it also told investors that the company would generate at least $9 billion in profit in 2016.Investor shock led the firm’s stock to plummet more than 14% at the time. Following SEC’s allegations that it misled  investors with an unrealistic profit expectation, Walgreens reached a settlement with the SEC by agreeing to pay a $34.5 million penalty - as announced on Friday.

Next month, shareholders will vote on whether to approve board nominees Robert Knowling Jr., Louis Miramontes and Arun Nayar – who, if elected, would replace current directors David Jessick, Myrtle Potter and Frank Savage.The shakedown of management comes close on the heels of failure of two buyout attempts - by the grocer Albertsons and pharmacy chain Walgreens respectively. Walgreens, however, did buy nearly 2,000 stores from Rite Aid Corp.